We isolated an 18-kilobase (kb) genomic selenoprotein P clone from a human placenta library and cloned, sequenced, and characterized the 5-flanking region of the human selenoprotein P gene. Sequence analysis revealed an intron between base pairs (bp) ؊13 and ؊14 upstream of the ATG codon and another one between bp 534 and 535 of the coding region. The major transcription start site of selenoprotein P in human HepG2 hepatocarcinoma cells was mapped to bp ؊70 by 5-rapid amplification of cDNA ends and by primer extension. 1.8 kb of the 5-flanking sequence were fused to a luciferase reporter gene. They exhibited functional promoter activity in HepG2 hepatocarcinoma and Caco2 colon carcinoma cells in transient transfection experiments. Treatment of transfected HepG2 cells with the cytokines interleukin 1␤, tumor necrosis factor ␣, and interferon ␥ repressed promoter activity. Nuclear extracts of interferon ␥-treated cells bound to a signal transducer and activator of transcription response element of the promoter in gel retardation experiments. By transfection of promoter-deletion constructs, a TATA box and a putative SP1 site were identified to be necessary for selenoprotein P transcription. These data indicate that the human selenoprotein P gene contains a strong promoter that is cytokine responsive. Furthermore, selenoprotein P, secreted by the liver, might react as a negative acute phase protein.
We isolated an 18-kilobase (kb) genomic selenoprotein P clone from a human placenta library and cloned, sequenced, and characterized the 5-flanking region of the human selenoprotein P gene. Sequence analysis revealed an intron between base pairs (bp) ؊13 and ؊14 upstream of the ATG codon and another one between bp 534 and 535 of the coding region. The major transcription start site of selenoprotein P in human HepG2 hepatocarcinoma cells was mapped to bp ؊70 by 5-rapid amplification of cDNA ends and by primer extension. 1.8 kb of the 5-flanking sequence were fused to a luciferase reporter gene. They exhibited functional promoter activity in HepG2 hepatocarcinoma and Caco2 colon carcinoma cells in transient transfection experiments. Treatment of transfected HepG2 cells with the cytokines interleukin 1␤, tumor necrosis factor ␣, and interferon ␥ repressed promoter activity. Nuclear extracts of interferon ␥-treated cells bound to a signal transducer and activator of transcription response element of the promoter in gel retardation experiments. By transfection of promoter-deletion constructs, a TATA box and a putative SP1 site were identified to be necessary for selenoprotein P transcription. These data indicate that the human selenoprotein P gene contains a strong promoter that is cytokine responsive. Furthermore, selenoprotein P, secreted by the liver, might react as a negative acute phase protein.
Selenoprotein P (SeP)
1 is a glycosylated plasma protein whose physiological function still remains unknown. It originally was purified as a 57-kDa species showing heparin binding capacity (1) (2) (3) (4) . However, recently at least five different forms with identical amino-terminal sequences have been isolated from rat plasma based on different SDS-polyacrylamide gel electrophoresis migration and heparin Sepharose affinity (5) .
cDNAs encoding selenoprotein P have been cloned and sequenced for man, rat, and mouse homologues. In all species, the open reading frame of the cDNA contains 10 TGA codons, each of which might encode a selenocysteine residue (6 -8) . The 3Ј-untranslated region of SeP mRNA contains two selenocysteine incorporation stem-loop structures (7, 9) . The amino acid composition of SeP is almost identical to that suggested by the cDNA sequence, although only 7-8 of the 10 predicted selenocysteine residues were detected by amino acid analysis (10) . Association of the protein with cell membranes has been described (11) . In bovine brain, the expression of a selenoprotein P-like protein with 12 selenocysteine residues has been demonstrated recently at the mRNA and protein levels (12) . Although SeP transcripts are found in nearly all tissues examined (13) (14) (15) , the liver is the main source for circulating SeP in the plasma (13) . In the rat, about two-thirds of the plasma selenium are contained in SeP (13) ; therefore, a role in selenium storage and distribution has been discussed (16) . However, former in vivo studies revealed a preferential synthesis of SeP compared with the cytosolic glutathione peroxidase under selenium-deficient conditions (17) . Some observations suggest a selenium storage function for cytosolic glutathione peroxidase rather than for SeP (17) (18) (19) . Studies in the rat model revealed a protective effect of SeP against liver injury caused by diquat or paraquat. Therefore, SeP might serve as an antioxidant in the extracellular space (20, 21) .
To get more information about the biological function and regulation of SeP gene expression, we isolated a genomic clone from a human placenta library and cloned and sequenced a 1.8-kb fragment of the 5Ј-flanking region of the human SeP gene. In transient transfection experiments of cultured hepatocarcinoma and colon carcinoma cells, the activity of this proximal promoter region and several deletion constructs was analyzed using chimeric luciferase reporters. We also identified the major start site of transcription at position Ϫ70 and an interferon ␥ (IFN␥)-responsive element at nucleotides Ϫ742 to Ϫ732. As secretion of liver proteins is affected by acute phase reaction (22) , the effect of different cytokines on SeP promoter activity was investigated; IFN␥ as well as tumor necrosis factor ␣ (TNF␣) and interleukin 1␤ (IL1␤) decreased promoter activity in transfected HepG2 cells, suggesting a repression of SeP expression during acute phase reaction.
EXPERIMENTAL PROCEDURES
Isolation of a Genomic Human SeP Clone, Subcloning, and Sequencing-A human placenta genomic library in the Lambda FixII-vector (Stratagene) was screened with a 1200-bp cDNA probe encoding the 5Ј part of the rat 16C1 SeP clone (kindly provided by Dr. K. Hill, Nashville, TN) according to a protocol provided by the manufacturer. A total of 4 ϫ 10 6 plaques were screened, yielding one positive clone. Lambda Fix phage DNA was isolated and digested with EcoRI, XbaI, and PstI (Fig.  1) . One 3.8-kb EcoRI, four XbaI (3, 2.1, 1.7, and 1.4 kb), and two PstI fragments (5.5 and 4.2 kb) were subcloned into the pBluescript SKIIϩ vector (Stratagene). Partial sequencing of the XbaI clones revealed that the 3-kb and the 2.1-kb fragments contained sequences of the 5Ј part of * This study was supported by Grants Wi 231/9-1 and Wi 231/9-2, TP1 from the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The 1 The abbreviations used are: SeP, selenoprotein P; kb, kilobase pair(s); bp, base pair(s); GAS, interferon-␥ activation site; IFN␥, interferon-gamma; PCR, polymerase chain reaction; RACE, rapid amplification of cDNA ends; IL, interleukin; TNF␣, tumor necrosis factor ␣; FCS, fetal calf serum; SRE, serum response element; LTR, long terminal repeat; CAT, chloramphenicol acetyltransferase; 5ЈDI, type I iodothyronine 5Ј-deiodinase; dATP␣S, adenosine 5Ј-O-(thiotriphosphate). the selenoprotein P coding region. The EcoRI and the 5.5-kb PstI clone were mapped to the 5Ј-untranslated region by Southern blot with oligonucleotide ID4 (5Ј-ACAACCACTCCAACGGGCC-3Ј, comprising the base pairs Ϫ33 to Ϫ14 with respect to the ATG codon).
Oligonucleotide primers for DNA sequencing reactions were purchased from Pharmacia (Uppsala, Sweden). Sequencing reactions were performed with T7 DNA polymerase (Pharmacia) according to the manufacturer's instructions. The reaction products were separated on a 6% polyacrylamide gel or, for long range sequence reading, after separation on a 3.5% polyacrylamide gel directly blotted onto a nylon membrane by using the GATC 1500-System Long Run DNA Sequencer (MWG-Biotech, Munich, Germany) according to the supplier's protocol. The nucleotide sequences of both strands were determined. DNA sequence analysis was performed using DNASIS for Windows software. For sequence comparison, we used the Genetics Computer Group (GCG) sequence analysis software package. The sequence was scanned through the non-redundant data bases GenBank, EMBL, DDBJ, and PDB.
Mapping of the Transcription Start Site-The 5Ј-end of the SeP mRNA was cloned after rapid amplification of cDNA ends (RACE) as modified by Edwards et al. (23) using the 5Ј-Amplifinder RACE kit from CLONTECH.
Poly(A)ϩ RNA for 5Ј-RACE was prepared from HepG2 cells with the Dynabead mRNA direct kit (Dynal, Oslo, Norway). For cDNA preparation, 2 g of HepG2 poly(A) ϩ RNA were incubated with primer ID3 (5Ј-CCTAGGAGCCAACTCTGAAT-3Ј), annealing at nucleotides 894 to 875 of the SeP open reading frame, and avian myeloblastosis virus reverse transcriptase for 30 min at 52°C. After ligation of an "anchor" to the cDNA according to the manufacturer's protocol, PCR was carried out with the primer ID9 (5Ј-GGCCACATCTATCATATATGAGGA-3Ј), corresponding to nucleotides 423 to 399 of the open reading frame of the human SeP. Amplification products were polished with the Klenow fragment of DNA polymerase I, phosphorylated, and cloned into the SmaI restriction site of pBluescript SKII for nucleotide sequence determination.
Primer Extension-15 ng of 32 P-labeled primer ID10 (5Ј-ACAGGTAT-CAGCTGGCTTGAAGAAG-3Ј, corresponding to base pairs 184 to 160 of the SeP cDNA) were annealed to 2 g of HepG2 poly(A) ϩ RNA for 10 min at 70°C. The primer was extended with avian myeloblastosis virus reverse transcriptase (Life Technologies, Inc., Eggenstein, Germany) in a total volume of 20 l containing 4 l of 5-fold reaction buffer, 1 mM dithiothreitol, 0.5 mM each of dATP, dCTP, dGTP, and dTTP, and 0.5 units/ml RNasin (Promega) for 60 min at 42°C. The products were subjected to ribonuclease I digestion (0.8 g/ml, Sigma, Deisenhofen, Germany) for 20 min at 37°C, extracted with phenol/CHCl 3 , ethanol precipitated, and resuspended in 4 l of H 2 O. 2 l of formamide containing stop buffer were added before separation on a 6% sequencing gel.
Construction of SeP Promoter/Luciferase Reporter Gene PlasmidsThe pGL2-basic vector, which contains a luciferase reporter gene for analysis of promoter activity of cloned fragments located immediately downstream of a polylinker, was obtained from Promega. The 1.8-kb promoter fragment of the 5.5-kb PstI subclone was amplified by PCR using the T7 promoter primer (annealing to the pBSSKIIϩ plasmid) and a modified ID4 primer with an additional BglII restriction site (5Ј-TGCTGCAGATCTGACAACCACTCCAACGGGCC-3Ј). The PCR fragments were treated with the Klenow fragment of DNA polymerase I (Life Technologies, Inc.) and purified from a 1% agarose gel using the Nucleotrap kit from Macherey & Nagel (Dü ren, Germany). Subsequently, the fragments were cleaved with KpnI and BglII and cloned into pGL2. Identity of isolated clones were confirmed by nucleic acid sequencing. One clone (pBK15), which contained the entire 1.8-kb promoter fragment and 50 bp of the pBluescript vector, was chosen for further studies. The reporter gene plasmids pGL2control and pCATcontrol (both obtained from Promega), used as controls, contain a luciferase or chloramphenicol acetyltransferase (CAT) gene downstream of a SV40 promoter. In the plasmid pGLh5ЈDIpr the promoter and enhancer regions of the human type I iodothyronine 5Ј-deiodinase (5ЈDI) are fused to the luciferase reporter gene (24) .
Preparation of Promoter-Deletion Constructs-Based on the nucleotide sequence of clone pBK15, several restriction enzyme sites were found suitable for the construction of a set of deletion clones. Fig. 2 shows the deletion constructs. pBK15 was partially digested for 1 h with StuI, purified from a 1% agarose gel as described above, and religated, resulting in the plasmid pStu3. For the construction of ⌬StuI, pStu3 was recut with StuI and with SmaI. Deletion of a 517-bp fragment of BK15 resulted in the plasmid p⌬Nsi, which by restriction with SmaI and NsiI was modified to ⌬Nsi/Sma. By restriction of BK15 with SmaI and PvuII (⌬Sma/Pvu), the 50-bp pBluescript fragment and 47 bp of the very 5Ј-end of the promoter sequence were eliminated (not shown). For the construction of Nsi/Stu, the Nsi fragment of pBK15 was cloned into the PstI site of pBluescript SKII. A fragment containing a 123-bp Nsi/Stu SeP promoter fragment and 20 bp of pBluescript was isolated by StuI/HindIII digestion. The fragment was cloned into the SmaI and HindIII sites of pGL2. To eliminate the retroviral LTR at the 5Ј-end of the cloned SeP promoter, the entire insert of BK15 was isolated by SmaI/BglII digestion. The insert was recut with BstEII for 2 h at 60°C. After purification, the insert and the BglII/SmaI cut vector were ligated. Afterward, the BstEII site of the insert was filled in by Klenow fragment treatment, and the resulting construct (⌬BstE/Sma) was ligated again. All constructs were confirmed by sequencing.
Cell Culture, Transfection, and Cytokine Treatment-HepG2 and Caco2 cells were obtained from the American Type Culture Collection. The human hepatocarcinoma line HepG2 (ATCC, HB 8065) was cultured in Dulbecco's modified Eagle's medium-F12 medium with 10% fetal calf serum and 1 mg/ml L-glutamine; the human colon carcinoma cell line Caco2 (ATCC, HTB37) was maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, 1% nonessential amino acids, 0.4 mM Hepes, 1 mg/ml L-glutamine. All cells were cultured in 75-mm 2 plastic flasks and incubated at 37°C in a humidified atmosphere consisting of 5% CO 2 and 95% air.
For transfection, the cells were seeded in 6-well plates and transfected at 50 -70% confluence. Plasmids for transfection were prepared and purified using a Midi prep kit purchased from Qiagen (Hilden, Germany) according to the supplier's protocol. For control of transfection efficiency, a plasmid containing the gene for bacterial ␤-galactosidase under the control of the constitutive SV40 promoter (pSV-␤-galactosidase, Promega) was cotransfected in each experiment. Liposomemediated transfection was performed using LipofectAMINE reagent (Life Technologies, Inc.) according to the method of Felgner et al. (25) . 10 l of LipofectAMINE and 1 g of BK15 plasmid plus 1 g of pSV-␤-galactosidase were diluted in 100 l of serum-free medium, respectively. The solutions were combined and incubated for 30 min at ambient temperature, 800 l of serum-free medium were added, and the solution was then carefully dripped onto the cells, which had been washed twice with serum-free medium. Caco2 cells were incubated for 6 h before the transfection solution was removed and replaced by serum-containing medium. After an incubation period of 20 h, the cells (30) . As intron length was not determined, the proportions of the constructs are not drawn to scale.
were harvested. HepG2 cells were incubated for 20 h with the transfection solution. Then the transfection solution was exchanged for serum-free medium. Cells were incubated for 20 h with this medium alone or with medium containing TNF␣ (50 ng/ml), IL1␤ (60 ng/ml), interleukin 6 (IL-6, 100 units/ml), or IFN␥ (100 ng/ml) (obtained from PBH, Hannover, Germany).
Determination of Luciferase and ␤-Galactosidase Activity-Cells were harvested in 180 l of 1 ϫ reporter lysis buffer (Promega). 20 l of the cell lysate were used for luciferase measurement, and 50 l (Caco2) or 100 l (HepG2) were applied for determination of ␤-galactosidase activity. Background luciferase expression from the vector was determined by transfection of the empty pGL2-basic plasmid. Analysis of luciferase activity was performed using the reporter gene assay provided by Promega in a microplate luminometer (EG&G Berthold, Bad Wildbad, Germany). ␤-Galactosidase activity was measured in a Uvicord III photometer (Pharmacia) according to a protocol provided by Promega. For control of transfection efficiency the obtained luciferase values were divided by the ␤-galactosidase activities.
Statistical Analysis-When appropriate, data were analyzed by analysis of variance. When the main effect was significant, the U test of Mann and Whitney was applied as a post hoc test to determine individual differences between means.
Analysis of DNA-Protein Interaction-The interaction of HepG2 nuclear proteins with an oligonucleotide corresponding to the nucleotides Ϫ745 to Ϫ726, comprising a putative interferon-␥ activation (GAS) site of the consensus sequence TTCNNNGAA (26) and flanking bases, was analyzed by electrophoretic mobility shift assays. HepG2 cells were seeded in 6-well plates in a culture medium with 10% FCS. At approximately 80% confluence, the culture medium was replaced by serumfree medium containing 1, 10, and 100 ng/ml IFN␥ for 10 min, 25 ng/ml for 5 and 15 min, or 50 ng/ml for 20 to 60 min, respectively. Afterward, the medium was removed and the cells were washed twice with phosphate-buffered saline.
Nuclear extracts were prepared according to a modified protocol of Grandison et al. (27; see also Ref. 28 ). Nuclear cell extracts (15 g of protein) were incubated in a reaction buffer of 10 mM Tris-HCl (pH 7.5), 100 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol, 0.2% Nonidet P-40, 5% glycerol containing 1 g of poly(dI⅐dC), and approximately 50 fmol of 32 P-labeled double-stranded oligonucleotide (15,000 -20,000 cpm) in a volume of 15 l for 30 min at ambient temperature. The oligonucleotides GASID1 (5Ј-GGTCTTCCAGGAAGTACGAC-3Ј) and its complementary GASID2 were annealed and end labeled using T4 polynucleotide kinase (Life Technologies, Inc.) and [␥-32 P]ATP (Amersham, Braunschweig, Germany).
For competition experiments, a 10-, 50-, and 100-fold molar excess of unlabeled GASID1/2 was added to the reaction mixture before the addition of reaction buffer. Additional competition experiments were carried out with a related oligonucleotide from the human aromatase promoter (29) (5Ј-GGTGTTTCCTGTGAAAGTTC-3Ј) as described above. Reaction mixtures were analyzed by non-denaturing polyacrylamide gel electrophoresis and autoradiography.
RESULTS

Mapping of the Transcription Initiation Site of the Human SeP
Gene-To map the transcription initiation site of SeP, the 5Ј-end of the mRNA from HepG2 cells was cloned using a modified RACE protocol. Poly(A) ϩ mRNA was isolated from the human hepatocarcinoma cell line HepG2, which showed high SeP expression in Northern blot experiments (14) . Specifically primed cDNA was prepared with an oligonucleotide annealing to nucleotides 894 to 875 of the open reading frame of the SeP mRNA. PCR amplification of the 5Ј-mRNA end was carried out with a nested oligonucleotide corresponding to the nucleotides 423 to 399 of the coding region. A single clear band of about 500 bp in length was demonstrated by gel electrophoretic analysis as shown in Fig. 3A . The band was eluted from the gel and subcloned into pBluescript vector (Fig. 3B) , and the nucleotide sequence of three clones was determined, which was the same for all clones. 459 bp were identical to the known SeP sequence. The remaining DNA stretch started with a G corresponding to position Ϫ70 with respect to the ATG translation start codon. The position of the transcription start site was also determined by primer extension analysis using primer ID10 (184 to 160) and HepG2 mRNA. To determine whether the length of the primer extension product (Fig. 3C, lane 1) fits to the transcriptional start site mapped by RACE, a sequencing reaction with the same primer and one of the RACE clones was run in parallel (Fig. 3C,  lanes 2-5) . To achieve appropriate exposure times, the sequencing reaction was carried out with [␣- Apart from a strong band supporting the finding that transcription initiation occurs at G (Ϫ70), an additional faint band was visible, which corresponds to C (Ϫ60).
Cloning and Sequence Analysis of the 5Ј Region of the SeP Gene-Screening of a human genomic library with a rat SeP clone resulted in the isolation of a single clone containing about 18 kb of inserted DNA. Partial sequencing of two XbaI subclones showed nucleotide sequence identity with the 5Ј part of the published human SeP cDNA sequence and at least two exon-intron boundaries, one between bp Ϫ13 and Ϫ14 upstream of the ATG codon and the other one between bp 534 and 535 of the coding region. Sequence information about known exon-intron boundaries is given in Fig. 1 and Fig. 4 . The exonintron boundaries mapped to date agree with the GT-AG rule The amplified band (q) was subcloned into the SmaI site of pBSSKIIϩ. The inserts were isolated by BamHI and EcoRI digestion (B) and sequenced for determination of the transcription start site. C, a primer extension experiment was carried out with HepG2 mRNA and a primer corresponding to base pairs 184 to 160 of the SeP coding region (lane 1). A 32 P sequencing ladder of one of the RACE clones with the same primer is shown in lanes 2-5. The sequence of the SeP amplification product is given in bold letters; the sequence of the "anchor-primer" is shown in italics. The major extension product is indicated by an arrow, and a minor one is indicated by an asterisk.
for splice sites.
Nucleotide sequence analysis of a 3.8-kb EcoRI subclone and a 5.5-kb PstI clone demonstrated that the clones contained 620 bp and 1800 bp, respectively, of the 5Ј-flanking region of the SeP gene. Location of the fragments with respect to the cloned 5Ј-end of SeP is shown in Fig. 1 . Based on sequence inspection, putative binding sites for several transcription factors were found as indicated in Fig. 4A . A TATA box was present at position Ϫ101 to Ϫ95, and a CAAT box was present at position Ϫ196 to Ϫ193. GC boxes (SP1 sites) characteristic for the promoters of housekeeping genes were found between Ϫ338 and Ϫ320, and two putative AP1 binding sites were identified at Ϫ408 to Ϫ402 and at Ϫ290 to Ϫ284. At nucleotides Ϫ742 to Ϫ732, the sequence CTTCCAGGAAG was found, which corresponds to elements (GAS elements) known for DNA binding of IFN␥-responsive transcription factors of the signal transducer and activator of transcription family (25) . Comparison of the nucleic acid sequence with entries in non-redundant data bases revealed sequence identity in 620 bp of human SeP promoter sequence submitted by Yasui et al. (30) . At bp Ϫ429 to Ϫ445, we found a stretch of 17 T nucleotides where Yasui had reported 16 Ts. A DNA stretch of the very 5Ј-end (bp Ϫ1808 to Ϫ1367) of the DNA fragment revealed sequence homology (84%) to an LTR of human endogenous viral DNA (31) .
Luciferase Activities of the SeP Promoter and Deletion Constructs-To assess basal promoter activity of the 5Ј-flanking region of the SeP gene, the full-length fragment (BK15) was transfected into HepG2 and Caco2 cells. In both cell lines, the luciferase activity of the promoter construct was 100 -1000 times higher than background activity, defined as luciferase activity of the promoterless pGL2 plasmid.
To identify sequences within the 5Ј-flanking region of the SeP gene, important for maximal basal promoter activity, several deletion constructs (Fig. 2) were transfected into HepG2 and Caco2 cells. Luciferase activities of the deletion constructs, expressed as percent of the values of the full-length construct BK15, are shown in Fig. 2C . The Stu3 construct (⌬ Ϫ1008 to Ϫ353) revealed no change in luciferase activity compared with the full-length construct in Caco2 and a slight, but not significant increase in HepG2 cells, whereas ⌬Stu (⌬ Ϫ1800 to Ϫ353) reached only 45% in HepG2 and 84% in Caco2 cells, respectively. Elimination of the sequence between Ϫ747 and Ϫ230 (⌬Nsi) resulted in luciferase activity of only 20% of BK15 in HepG2 cells and 52% in Caco2 cells, whereas removal of the complete 5Ј region upstream of nucleotide Ϫ230 (⌬Nsi/Sma) led to a slight but significant increase in promoter activity to 45% (HepG2, p Ͻ 0.001) and 75% (Caco2, p Ͻ 0.005) relative to control BK15 expression. By cloning a 123-bp Nsi/Stu fragment into the pGL2 plasmid (Nsi/Stu), 3% (HepG2) and 9% (Caco2) of the full-length construct's activity was achieved. However, compared with the promoterless pGL2, luciferase activity of Nsi/Stu was increased up to 40 times. In contrast, transfection of HepG2 cells with a 105-bp fragment derived from the human 5ЈDI promoter (24) , which constitutes the basal promoter of 5ЈDI, led only to an increase of luciferase activity by a factor of 3 to 4 (data not shown). This ensures that the Nsi/Stu region of the SeP promoter containing the SP1 and one AP1 site confers marked activation to the luciferase reporter construct. Elimination of the remaining stretch of pBluescript in BK15 by SmaI/PvuII digestion had no effect on promoter efficiency (data not shown). Removal of the retroviral LTR (⌬BstE/Sma) did not reduce SeP promoter activity. In contrast, a significant (p Ͻ 0.005) increase to 140% was obtained in HepG2 cells.
Nuclear Protein Binding to the Putative IFN␥ Response Element from the SeP Promoter-HepG2 cells were treated with increasing concentrations of IFN␥ before nuclear extracts were prepared and analyzed by electrophoretic mobility shift assays with an oligonucleotide comprising the GAS element described in Fig. 4A . The oligonucleotide used for the electrophoretic mobility shifts also contains the flanking bases from the SeP promoter. In the IFN␥-treated probes, a specific band appeared whose intensity correlated with increasing IFN␥ concentrations (Fig. 5A, lanes 2-4) . Specificity was ensured as incubation with an excess of unlabeled probe led to the dose-dependent disappearance of the slower migrating band (lanes 7-9) . In contrast, a nonspecific band present in every lane was not competed by excess of unlabeled probe. Additional competition experiments with a related oligonucleotide derived from the aromatase promoter (29) did not influence IFN␥-dependent protein binding to the GASID1/2 oligonucleotide (lanes 10 -12) . The time course of protein-DNA interaction is shown in lanes 5 and 6 and Fig. 5B . While after 5 min no retarded band appeared, it was fully present after 15 min of IFN␥ treatment, persisting for at least 60 min.
Responsiveness of the SeP Promoter to Cytokine TreatmentHepG2 cells were treated with cytokines for 20 h after transfection of the 1.8-kb SeP promoter construct, and luciferase activities were determined as shown in Table I . IL-6 had no significant effect on promoter activity, whereas IL1␤, IFN␥, and TNF␣ revealed a significant repression of luciferase activ- FIG. 5 . Electrophoretic mobility shift assay of the putative IFN␥ response (GAS) element TTCCAGGAA in the 5-flanking region of the SeP gene. Oligonucleotide GASID1/2 5Ј-GGTCTTC-CAGGAAGTACGAC-3Ј, corresponding to nucleotides Ϫ745 to Ϫ726 of the 5Ј region of the SeP gene, comprises a putative IFN␥ response element. By electrophoretic mobility shift analysis, its capacity to bind nuclear proteins prepared from control and IFN␥-stimulated HepG2 cells was tested. A, lane 1 shows control HepG2 extract, lanes 2-4 show extracts from cells treated with 1, 10, and 100 ng/ml IFN␥ for 10 min, respectively. In lanes 5 and 6, nuclear extracts that were prepared of HepG2 cells previously treated with 25 ng/ml IFN␥ for 5 min (lane 5) and 15 min (lane 6) are shown. A black circle indicates a specific DNA-protein complex that is not present in the control lane (1) and is suppressed by a 10-, 50-, and 100-fold molar excess of unlabeled GASID1/2 oligonucleotide (lanes 7-9) but not by a 10, 50, and 100-fold molar excess of a related oligonucleotide derived from the aromatase promoter (lanes 10 -12) . For lanes 7-12, the same nuclear extract was used as for lane 4 (100 ng/ml IFN␥, 10 min). A white circle denotes unspecific DNA-protein complexes, present in every lane. Free oligonucleotide is indicated by a square. B, DNA-protein interaction persists from 20 to 60 min. Lane 5 shows control extracts, and lanes 1-4 show extracts from HepG2 cells treated with 50 ng/ml IFN␥ for 20, 30, 45, and 60 min, respectively. ity (46, 40, and 55% of control, respectively). Expression of ␤-galactosidase was also affected by cytokine treatment (Table  I) . Therefore, division of the luciferase activities by ␤-galactosidase values altered the relative levels of repression corrected for transfection efficiency as shown in Fig. 6 . Repression of SeP promoter activity by cytokine treatment was significant for IL1␤ to 16% (p Ͻ 0.005), IFN␥ to 60% (p Ͻ 0.0002), and TNF␣ to 47% of control (p Ͻ 0.02). As cytokine treatment influenced the expression of the ␤-galactosidase reporter gene, we tested whether there may also be an influence on the stability of luciferase mRNA. A luciferase construct under the control of a weak promoter (h5ЈDIpr) or a strong viral promoter (pGL2control) was transfected into HepG2 cells under the same conditions. The luciferase activity deriving from the pGL2control reporter plasmid was in fact induced 2.3-fold by IL1␤ compared with the untreated controls (data not shown). In contrast, luciferase expression from the h5ЈDIpr construct was reduced by IL1␤ but not altered by either TNF␣ or IFN␥. Thus, we can rule out an unspecific effect of IL1␤, TNF␣, or IFN␥ on luciferase mRNA. We also tested the influence of the above mentioned cytokines on the pCATcontrol vector. The expression of chloramphenicol acetyltransferase was also increased 2-fold by treatment with IL1␤ in HepG2 cells.
Addition of fetal calf serum to the culture medium led to a decrease of the relative luciferase activity in HepG2 and Caco2 cells. In HepG2 cells, the promoter activity was significantly reduced to 28% by 10% FCS (p Ͻ 0.01). MTT and trypan blue tests revealed no difference in cell viability of HepG2 cells grown under serum-free conditions compared with cells that were supplemented with 10% FCS after transfection.
The selenium content of the culture medium and fetal calf serum, respectively, was measured by neutron activation analysis. The medium selenium content was below the limit of detection, whereas serum analysis found a final concentration of approximately 10 nM in the 10% serum-containing culture medium.
DISCUSSION
Except for decreased secretion of SeP from rat liver under selenium deficiency (32, 33) , no biological regulation of SeP expression is known; however, SeP can serve as a valuable marker for systemic selenium status (34) . Therefore, we isolated a genomic clone containing sequences of the 5Ј-flanking region of the gene to study the regulation of SeP gene expression.
We also mapped the major transcription initiation site to G (Ϫ70) by 5Ј-RACE, which was supported by primer extension. A minor start point identified at C (Ϫ60) was not found by RACE.
A recent report by Yasui et al. (30) describes the major transcription start site at Ϫ60 and a minor one at position Ϫ74 using primer extension and human liver mRNA. Different methods and sources of mRNA, HepG2 versus liver, might result in these differences. Our data on the structure of the human SeP gene are compatible with the proposed intron-exon organization for the human SeP gene (30) . However, the exact size of all introns is not yet known.
1.8 kb of the 5Ј-flanking region of SeP fused to the firefly luciferase gene exhibited high luciferase activities by transfection of HepG2 and Caco2 cells. Several classical regulatory elements within the promoter region might contribute to this strong promoter activity. Interestingly, fetal calf serum decreased the activity in both cell types, which was not a consequence of altered cell viability. However, sequence inspection did not reveal the presence of a consensus serum response element (SRE) (35) , suggesting a novel type of negative SRE within the SeP promoter. To our knowledge, no inhibitory SRE has been described to date. In contrast to the inhibitory serum effects on the "negative SRE" in the SeP promoter, serum effects were analyzed with previously described positive SREs, revealing marked stimulation of reporter gene expression in different cell contexts (35) (36) (37) . The final selenium concentration in the serum-containing medium was determined to be approximately 10 nM. Additional experiments revealed that selenium concentrations up to 100 nM did not affect SeP promoter activity (data not shown). Therefore, a direct inhibitory influence of selenium toward SeP promoter activity is not likely.
As secretion of several liver proteins is inhibited under acute phase conditions (22) , we analyzed whether SeP gene expression was reduced by cytokines. Except for IL-6, all other cytokines we examined significantly decreased promoter activity, suggesting a repression of SeP expression during acute phase reaction. Among the cytokines tested, IL1␤ had the strongest inhibitory effect. We refer to the absolute luciferase activities in these experiments because we consistently observed that IL1␤ increased ␤-galactosidase expression by a factor of 2.5 to 4 from the plasmid pSV-␤-galactosidase that was used as an internal standard. Normalization of luciferase activity for transfection efficiency therefore would lead to an overestimation of the inhibitory effect of IL1␤ on the SeP promoter.
In addition, we conducted several experiments to test whether the inhibitory effect of IL1␤ was indeed specific or due to destabilization of luciferase transcripts by cytokines. IL1␤ stimulated luciferase and CAT expression from control vectors containing SV40 promoters, whereas it diminished the activity of a luciferase reporter plasmid containing the promoter of the human 5Ј-deiodinase. This suggests that repression of the chimeric SeP and 5ЈDI promoter activities by IL1␤ is caused by elements in the promoter sequence and not due to destabilization of luciferase transcripts. Similar to IL1␤, TNF␣ decreased the activity of the promoter construct and stimulated ␤-galactosidase expression, whereas IFN␥ reduced the SeP promoter activity. However, normalization for ␤-galactosidase in this case might lead to an underestimation of this effect. This indicates specific inhibitory effects of individual cytokines directly on the SeP promoter as well as both stimulatory and inhibitory effects on SV40 promoter elements contained in the control vectors of luciferase, CAT, and ␤-galactosidase reporter constructs.
By electrophoretic mobility shift experiments with a single copy of a palindromic sequence, comprising base pairs Ϫ742 to Ϫ732 and flanking bases of the SeP promoter, a putative GAS response element was identified to bind nuclear protein of HepG2 cells after IFN␥ treatment. As IFN␥ caused repression of promoter activity and antibodies against signal transducer and activator of transcription proteins (26) produced no supershifted bands, the protein binding to the GAS element might be a repressor of the type described by Yamagata et al. (38) , who isolated a transcription factor that negatively regulates the activity of interferon-regulated genes.
Transfection of promoter deletion constructs led to the identification of stretches within the promoter necessary for maximal basal activity. Elimination of a 517-bp NsiI fragment led to decreased luciferase activity. However, deletion of an Stu3 fragment, partially overlapping the NsiI fragment and containing the described GAS element, did not alter promoter efficiency. Thus, it may be assumed that the GAS element does not influence basal SeP transcription but that the remaining 123 bp, which contain a GC stretch for SP1 binding and a putative AP1 site, must be of essential importance. This was supported by the finding that the 123-bp Nsi/Stu fragment fused to the luciferase gene actually exhibited luciferase activity 40-fold above background, whereas a similar fragment from the human 5ЈDI promoter was by an order of magnitude less potent. Plasmid ⌬Nsi/Sma contains only 160 bp upstream of the determined transcription initiation site, comprising the putative TATA and CAAT box. As the ⌬Nsi/Sma construct exhibited markedly enhanced promoter activity, the actual use of these elements for basal transcription is likely.
Deletion of the entire 5Ј region of the ⌬Nsi clone increased luciferase activity, indicating a silencing element in this part of the promoter. A negative regulatory element may be located between bp -1356 and bp -1370 where a TC-repeat, similar to previously described silencer elements (39) is found. As elimination of the 5Ј region of the Stu3 clone diminished promoter activity, also positive regulatory elements must be located near the 5Ј-end. One can exclude intrinsic promoter or enhancer activity of the retroviral LTR at the very 5Ј-end, as deletion of the entire LTR fragment did not decrease promoter activity.
In summary, our results present first insight into the regulation of the human SeP gene and offer experimental tools for the clarification of the yet unknown function of this major selenoprotein in rat and human serum.
